The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
- Observation: Case-Only
- Perspective: Prospective
- Sampling: Non-Probability Sample
Patients with an acute ischemic stroke admitted to our stroke unit and treated with clopidogrel
|Type||Measure||Time Frame||Safety Issue|
|Primary||Result of platelet function test||one day||No|